potassium citrate 15 MEQ Extended Release Oral Tablet [Urocit-K]
RxNorm concept 898517, branded drug (sbd). Prescribable name: UROCIT-K 15 MEQ Extended Release Oral Tablet.
- RxCUI
- 898517
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/898517 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
K+ citrate 15 MEQ Extended Release Oral Tablet [Urocit-K]; Pot citrate 15 MEQ Extended Release Oral Tablet [Urocit-K]; Urocit-K 15 MEQ Extended Release Oral Tablet; Urocit-K 1620 MG Extended Release Oral Tablet
Related concepts
- potassium citrate 15 MEQ (SCDC, consists of)
- potassium citrate 15 MEQ [Urocit-K] (SBDC, consists of)
- Extended Release Oral Tablet (DF, has dose form)
- Urocit-K (BN, has ingredient)
- potassium citrate 15 MEQ Extended Release Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 898517 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/898517 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 898517. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.